Judge yourself over the past eight weeks, and you’ll end up either disappointed or deluded.
Browsing: Yahoo
Micro-Mechanics, Nanofilm Technologies and Civmec have outpaced the STI in 2026, with profits growing faster than sales.
DBS, Keppel and Keppel REIT are rewarding investors with special dividends, but can their ordinary payouts keep growing?
Singapore REITs have fallen 8% while the STI has climbed 25%, creating a sharp performance gap. Should income investors be concerned, or could the sector’s weakness create opportunities for long-term investors?
How does CPF SA compounding compare with blue-chip dividend growth? We put S$10,000 into both to see how the numbers could differ over 10, 20 and 30 years.
Three Temasek-linked blue chips beat the STI’s 19.2% total return in 2026. Here’s what their latest results reveal about profit growth and dividends.
High dividend yields can signal opportunity or trouble, so we screen five SGX yielders to assess their earnings, cash flow and payout sustainability.
Prominent tech giants are falling as much as 30% from their peaks. But what looks like a rare stock market sale could turn out to be a potential value trap.
Three SGX small-cap stocks grew profits by 24% or more this earnings season, but investors should look beyond profit growth to the cash supporting those gains.
With S$30,000 to invest, these four Singapore stocks offer a mix of dividend income, business resilience and long-term growth potential for a balanced portfolio.
Is a S$3,000 gold bar a safer investment than Singapore stocks? We compare gold and shares to see which could better protect and grow your wealth.
OCBC outperformed expectations in 3Q2026 as DBS and UOB fell short, but investors should look beyond the beat or miss to assess each bank’s strength.
Singtel, SATS and SIA report within three days, giving investors fresh clues on earnings, growth and how each business is navigating current challenges.
This week’s Smart Reads explores Singapore blue chips and dividend stocks rewarding shareholders, resilient companies that outperformed the STI in October, and whether now is a good time to invest. We also examine REIT results, CapitaLand Investment and long-term portfolio choices.
Singapore’s banks reported mixed quarterly results and the NASDAQ slid into a correction, while Grab raised its full-year outlook and SGX RegCo will take on prospectus reviews.
Three S-REITs raised their DPU this earnings season despite elevated interest rates — here’s what their latest results reveal.
The US market sell-off has created potential bargains among S&P 500 stocks. Here are five companies worth considering for their fundamentals, competitive advantages and long-term growth prospects.
The STI ETF fell 5.5% in October, but four blue-chip S-REITs stayed in the green. FCT, CICT, FLCT and MLT also outperformed the broader S-REIT index.
Singapore REITs have fallen under pressure, but three could recover faster than the sector. We examine their property fundamentals, debt levels and potential catalysts.
OCBC delivered record profit in 1H2026, but fees, trading and insurance drove much of the growth. Here are three key metrics to watch ahead of its 3Q update.